We are live on ! Find out more
AYTU icon

AYTU BioPharma

9 hedge funds and large institutions have $3.9M invested in AYTU BioPharma in 2019 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

341% more capital inflows, than outflows

Capital inflows: $2.47M | Capital outflows: $559K

10% less funds holding

Funds holding: 10 → 9 (-1)

20% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 5

44.93% less ownership

Funds ownership: 58.94% → 14.01% (-45%)

Holders
9
Holders Change
-1
Holders Change %
-10%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
2
Reduced
–
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

AYTU Hedge Fund Activity: Q1 2019 in Review

9 of the 4,635 institutional investors tracked by Wall St. Rank reported a position in AYTU BioPharma (AYTU) for Q1 2019, worth a combined $3.9M — up 365% from $839K a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of AYTU and 4 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 2 added.

The largest buyer was Armistice Capital, adding an estimated $2.37M. The largest seller was Sabby Management, exiting entirely with an estimated $408K sold.

  • 9 institutional investors held AYTU BioPharma (AYTU) as of Q1 2019, down from 10 in Q4 2018.
  • Funds reported $3.9M of AYTU BioPharma stock for Q1 2019, up 365% quarter-over-quarter.
  • 4 funds opened new AYTU BioPharma positions in Q1 2019 and 5 closed out, a net change of -1 holder.
  • The largest AYTU BioPharma buyer in Q1 2019 was Armistice Capital, an estimated $2.37M added.
  • The largest AYTU BioPharma seller in Q1 2019 was Sabby Management, an estimated $408K sold.

Based on aggregated 13F filings for Q1 2019.